Raymond James Financial
ACHV icon

Raymond James Financial’s Achieve Life Sciences ACHV Stock Holding History

Raymond James Financial’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.57M Sell
546,318
-95,607
-15% -$456K ﹤0.01% 3016
2026
Q1 		$1.89M Buy
641,925
+42,246
+7% +$188K ﹤0.01% 3405
2025
Q4 		$2.98M Buy
599,679
+143,307
+31% +$625K ﹤0.01% 2936
2025
Q3 		$1.44M Buy
456,372
+161,314
+55% +$443K ﹤0.01% 3428
2025
Q2 		$667K Buy
295,058
+107,218
+57% +$305K ﹤0.01% 3827
2025
Q1 		$502K Buy
187,840
+30,321
+19% +$94.3K ﹤0.01% 3940
2024
Q4 		$554K Buy
+157,519
New +$714K ﹤0.01% 3845

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Raymond James Financial's ACHV Position: Q2 2026 in Review

Raymond James Financial reduced its Achieve Life Sciences (ACHV) stake by 15% in Q2 2026, selling an estimated $456K and leaving 546,318 shares worth $3.57M. The position accounts for ﹤0.01% of the portfolio, ranked #3016.

Raymond James Financial first reported a position in ACHV in Q4 2024 and has held it in 7 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Raymond James Financial held 546,318 shares of Achieve Life Sciences worth $3.57M as of Q2 2026.
  • Raymond James Financial sold 95,607 Achieve Life Sciences shares in Q2 2026, an estimated $456K.
  • Achieve Life Sciences made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3016 holding.
  • Raymond James Financial first reported a position in Achieve Life Sciences in Q4 2024 and has held it in 7 quarters since.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.